{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:46:42Z","timestamp":1793825202467,"version":"4.6.1"},"reference-count":70,"publisher":"Rambam Health Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rambam Maimonides Med J"],"DOI":"10.5041\/rmmj.10262","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T10:26:16Z","timestamp":1477909576000},"page":"e0035","source":"Crossref","is-referenced-by-count":41,"title":["Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update"],"prefix":"10.5041","volume":"7","author":[{"given":"Gideon","family":"Nesher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel S.","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2983","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3899\/jrheum.150557","article-title":"The incidence of primary systemic vasculitis in Jerusalem: a 20-year hospital-based retrospective study","volume":"43","author":"Nesher","year":"2016","unstructured":"1. Nesher G, Ben-Chetrit E, Mazal B, Breuer GS. The incidence of primary systemic vasculitis in Jerusalem: a 20-year hospital-based retrospective study. J Rheumatol 2016;43:1072-7.","journal-title":"J Rheumatol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Catanoso M, Macchioni P, Boiardi L, et al. Incidence, prevalence and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year period. Arthritis Care Res (Hoboken) 2016 May 23. [Epub ahead of print].","DOI":"10.1136\/annrheumdis-2016-eular.3979"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1136\/annrheumdis-2013-204652","article-title":"Incidence and mortality rates of biopsy-proven giant cell arteritis in Southern Sweden","volume":"74","author":"Mohammad","year":"2015","unstructured":"3. Mohammad AJ, Nilsson JA, Jacobsson LT, Merkel PA, Turesson C. Incidence and mortality rates of biopsy-proven giant cell arteritis in Southern Sweden. Ann Rheum Dis 2015;74:993-7.","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.20227","article-title":"Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period","volume":"51","author":"Salvarani","year":"2004","unstructured":"4. Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004;51:264-8.","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.semarthrit.2015.06.009","article-title":"Prevalence of ischemic complications in patients with giant cell arterirtis presenting with apparently isolated polymyalgia rheumatica","volume":"45","author":"Narvaez","year":"2015","unstructured":"5. Narvaez J, Estrada P, Lopez-Vives L, et al. Prevalence of ischemic complications in patients with giant cell arterirtis presenting with apparently isolated polymyalgia rheumatica. Semin Arthritis Rheum 2015;45: 328-33.","journal-title":"Semin Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamaneurol.2015.2101","article-title":"Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis","volume":"72","author":"Nagel","year":"2015","unstructured":"6. Nagel MA, White T, Khmeleva N, et al. Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol 2015;72:1281-7.","journal-title":"JAMA Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/art.38631","article-title":"In search of a candidate pathogen for giant cell arteritis: sequencing-based characterization of the giant cell arteritis microbiome","volume":"66","author":"Bhatt","year":"2014","unstructured":"7. Bhatt AS, Manzo VE, Pedamallu CS, et al. In search of a candidate pathogen for giant cell arteritis: sequencing-based characterization of the giant cell arteritis microbiome. Arthritis Rheumatol 2014;66: 1939-44.","journal-title":"Arthritis Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2013.161","article-title":"Immune mechanisms in medium and large vessel vasculitis","volume":"9","author":"CM","year":"2013","unstructured":"8. Weyand CM, Goronzy JJ. Immune mechanisms in medium and large vessel vasculitis. Nat Rev Rheumatol 2013;9:731-40.","journal-title":"Nat Rev Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Ly KH, Regent A, Tamby MC, Mouthon L. Pathogenesis of giant cell arteritis: more than just an inflammatory condition? Autoimmun Rev 2010;9;635-45.","DOI":"10.1016\/j.autrev.2010.05.002"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev 2012;11: A544-5.","DOI":"10.1016\/j.autrev.2012.01.003"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMra022694","article-title":"Medium and large vessel vasculitis","volume":"349","author":"CM","year":"2003","unstructured":"11. Weyand CM, Goronzy JJ. Medium and large vessel vasculitis. N Eng J Med 2003;349:160-9.","journal-title":"N Eng J Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/ard.2003.011692","article-title":"Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study","volume":"63","author":"Moosig","year":"2004","unstructured":"12. Moosig F, Czech N, Mehl C, et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 2004;63:870-3.","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatic: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","unstructured":"13. Blockmans D, De Ceuninck I, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatic: a prospective study in 35 patients. Rheumatology (Oxford) 2007; 46:672-7.","journal-title":"Rheumatology (Oxford)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/01.md.0000119761.27564.c9","article-title":"Risk factors for cranial ischemic complications in giant cell arteritis","volume":"83","author":"Nesher","year":"2004","unstructured":"14. Nesher G, Berkun Y, Mates M, et al. Risk factors for cranial ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004;83:114-22.","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-200301000-00001","article-title":"Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature","volume":"82","author":"Ruegg","year":"2003","unstructured":"15. Ruegg S, Engelter S, Jeanneret C, et al. Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine (Baltimore) 2003;82:1-12.","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment","volume":"41","author":"Gonz\u00e1lez-Gay","year":"1998","unstructured":"16. Gonz\u00e1lez-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998;41: 1497-504.","journal-title":"Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1001\/archneur.57.4.581","article-title":"Deterioration of giant cell arteritis with corticosteroid therapy","volume":"57","author":"Staunton","year":"2000","unstructured":"17. Staunton H, Stafford F, Leader M, O'Riordain D. Deterioration of giant cell arteritis with corticosteroid therapy. Arch Neurol 2000;57:581-4.","journal-title":"Arch Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis","volume":"79","author":"Gonz\u00e1lez-Gay","year":"2000","unstructured":"18. Gonz\u00e1lez-Gay MA, Garc\u00eda-Porrua C, Liorca J, et al. Visual manifestations of giant cell arteritis. Medicine (Baltimore) 2000;79:283-92.","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.12968\/hmed.2011.72.1.26","article-title":"Ophthalmic manifestations of giant cell arteritis","volume":"72","author":"Waqar","year":"2011","unstructured":"19. Waqar S, Salman R, Sleep T. Ophthalmic manifestations of giant cell arteritis. Br J Hosp Med 2011;72: 26-30.","journal-title":"Br J Hosp Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3899\/jrheum.140188","article-title":"Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort","volume":"42","author":"Singh","year":"2015","unstructured":"20. Singh AG, Kermani TA, Krowson CS, Weyand CM, Matteson EL, Warrington KJ. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. J Rheumatol 2015;42:309-15.","journal-title":"J Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis","volume":"112","author":"Danesh-Meyer","year":"2005","unstructured":"21. Danesh-Meyer H, Savino PJ, Gamble GD. Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology 2005;112:1098-103.","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00005792-200301000-00002","article-title":"Audiovestibular manifestations in giant cell arteritis: a prospective study","volume":"82","author":"Amor-dorado","year":"2003","unstructured":"22. Amor-dorado JC, Llorca J, Garcia-Porrua C, Costa C, Perez-Fernandez N, Gonzalez-Gay MA. Audiovestibular manifestations in giant cell arteritis: a prospective study. Medicine (Baltimore) 2003;82:13-26.","journal-title":"Medicine (Baltimore)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1002\/art.11353","article-title":"Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years","volume":"48","author":"Nuenninghof","year":"2003","unstructured":"23. Nuenninghof DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48:3522-31.","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/annrheumdis-2013-204113","article-title":"The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population in the UK","volume":"74","author":"Robson","year":"2015","unstructured":"24. Robson JC, Kiran A, Maskell J, et al. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population in the UK. Ann Rheum Dis 2015;74:129-35.","journal-title":"Ann Rheum Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/rheumatology\/39.3.283","article-title":"The incidence and clinical characteristics of peripheral arthritis in polymyalgia rheumatica and temporal arteritis: a prospective study of 231 cases","volume":"39","author":"JT","year":"2000","unstructured":"25. Gran JT, Myklebust G. The incidence and clinical characteristics of peripheral arthritis in polymyalgia rheumatica and temporal arteritis: a prospective study of 231 cases. Rheumatology (Oxford) 2000;39: 283-7.","journal-title":"Rheumatology (Oxford)"},{"key":"ref25","unstructured":"26. Olivieri I, Salvarani C, Cantini F. Remitting distal extremity swelling with pitting edema: a distinct syndrome or a clinical feature of different inflammatory rheumatic disease? J Rheumatol 1997;24:249-52."},{"key":"ref26","unstructured":"27. Pease CT, Haugeberg G, Morgan AW, Montague B, Hensor EM, Bhakta BB. Diagnosing late-onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm study. J Rheumatol 2005;32:1043-6."},{"key":"ref27","unstructured":"28. Gonz\u00e1lez-Gay MA, Garc\u00eda-Porrua C, Salvarani C, Olivieri I, Hunder GG. Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica. Clin Exp Rheumatol 2000;18:755-9."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2","article-title":"Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study","volume":"45","author":"Salvarani","year":"2001","unstructured":"29. Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Rheum 2001;45:140-5.","journal-title":"Arthritis Rheum"},{"key":"ref29","unstructured":"30. Breuer GS, Nesher R, Nesher G. Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Clin Exp Rheumatol 2008;26:1103-6."},{"key":"ref30","unstructured":"31. Breuer GS, Nesher R, Nesher G. Effect of biopsy length on the rate of positive temporal artery biopsies. Clin Exp Rheumatol 2009;27(1 suppl 52):S10-13."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3899\/jrheum.080792","article-title":"Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis","volume":"36","author":"Breuer","year":"2009","unstructured":"32. Breuer GS, Nesher G, Nesher R. Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol 2009;36:794-6.","journal-title":"J Rheumatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semarthrit.2006.12.005","article-title":"Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis","volume":"37","author":"Narvaez","year":"2007","unstructured":"33. Narvaez J, Bernard B, Roig-Vilaseca D, et al. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum 2007;37:13-19.","journal-title":"Semin Arthritis Rheum"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","article-title":"Color duplex ultrasonography in the diagnosis of temporal arteritis","volume":"337","author":"Schmidt","year":"1997","unstructured":"34. Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997;337:1336-42.","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Maldini C, Depinay-Dhellemmes C, Tra TT, et al. Limited value of temporal artery ultrasonography examinations for diagnosis of giant cell arteritis: analysis of 77 subjects. J Rheumatol 2010;37;2326-30.","DOI":"10.3899\/jrheum.100353"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1148\/radiol.14140056","article-title":"Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis - results from a multicenter trial","volume":"273","author":"Klink","year":"2014","unstructured":"36. Klink T, Geiger J, Both M, et al. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis - results from a multicenter trial. Radiology 2014;273:844-52.","journal-title":"Radiology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1002\/art.23699","article-title":"Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis","volume":"58","author":"Bley","year":"2008","unstructured":"37. Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum 2008;58:2574-8.","journal-title":"Arthritis Rheum"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1749-6632.2011.06021.x","article-title":"PET in vasculitis","volume":"1228","author":"Blockmans","year":"2011","unstructured":"38. Blockmans D. PET in vasculitis. Ann N Y Acad Sci 2011;1228:64-70.","journal-title":"Ann N Y Acad Sci"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Chatelain D, Duhaut P, Loire R, et al. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica? Arthritis Rheum 2008;58:2565-73.","DOI":"10.1002\/art.23700"},{"key":"ref39","unstructured":"40. Chakravarty K, Pountain G, Merry P, Byron M, Hazleman B, Scott DG. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1995;22:1694-7."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/rheumatology\/37.2.208","article-title":"Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases","volume":"37","author":"Manna","year":"1998","unstructured":"41. Manna R, Latteri M, Cristiano G, Todaro L, Scuderi F, Gasbarrini G. Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Br J Rheumatol 1998;37:208-10.","journal-title":"Br J Rheumatol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/rheumatology\/39.10.1089","article-title":"A longitudinal study of 58 biopsy-proven cases","volume":"39","author":"Liozon","year":"2000","unstructured":"42. Liozon E, Roblot P, Paire D, et al. Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases. Rheumatology (Oxford) 2000;39:1089-94.","journal-title":"Rheumatology (Oxford)"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/sarh.2001.23499","article-title":"Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis","volume":"31","author":"Espinosa","year":"2001","unstructured":"43. Espinosa G, T\u00e0ssies D, Font J, et al. Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis. Semin Arthritis Rheum 2001;31:12-20.","journal-title":"Semin Arthritis Rheum"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2249.2002.01751.x","article-title":"Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatic","volume":"127","author":"Schmits","year":"2002","unstructured":"44. Schmits R, Kubuschok B, Schuster S, Preuss KD, Pfreundschuh M. Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatic. Clin Exp Immunol 2002;127:379-85.","journal-title":"Clin Exp Immunol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/annrheumdis-2011-200413","article-title":"Association of ferritin autoantibodies with giant cell arteritis\/polymyalgia rheumatica","volume":"71","author":"Baerlecken","year":"2012","unstructured":"45. Baerlecken NT, Linnemann A, Gross WL, et al. Association of ferritin autoantibodies with giant cell arteritis\/polymyalgia rheumatica. Ann Rheum Dis 2012;71:943-7.","journal-title":"Ann Rheum Dis"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/03009742.2012.733959","article-title":"Epitope mapping of antibodies against ferritin heavy chain in giant cell arteritis and polymyalgia rheumatica","volume":"42","author":"Gro\u00dfe","year":"2013","unstructured":"46. Gro\u00dfe K, Schmidt RE, Witte T, Baerlecken NT. Epitope mapping of antibodies against ferritin heavy chain in giant cell arteritis and polymyalgia rheumatica. Scand J Rheumatol 2013;42:215-19.","journal-title":"Scand J Rheumatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/annrheumdis-2012-202963","article-title":"Contribution of antiferritin antibodies to diagnosis of giant cell arteritis","volume":"72","author":"R\u00e9gent","year":"2013","unstructured":"47. R\u00e9gent A, Ly KH, Blet A, et al. Contribution of antiferritin antibodies to diagnosis of giant cell arteritis. Ann Rheum Dis 2013;72:1269-70.","journal-title":"Ann Rheum Dis"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","unstructured":"48. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.","journal-title":"Arthritis Rheum"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ajo.2012.03.045","article-title":"Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis","volume":"154","author":"Murchison","year":"2012","unstructured":"49. Murchison AP, Gilbert ME, Bilyk JR, et al. Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis. Am J Ophthalmol 2012;154:722-9.","journal-title":"Am J Ophthalmol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.7326\/0003-4819-129-5-199809010-00013","article-title":"The use and misuse of classification and diagnostic criteria for complex disease","volume":"129","author":"Hunder","year":"1998","unstructured":"50. Hunder GG. The use and misuse of classification and diagnostic criteria for complex disease. Ann Intern Med 1998;129:417-18.","journal-title":"Ann Intern Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1136\/ard.60.11.1021","article-title":"Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study","volume":"60","author":"Caporali","year":"2001","unstructured":"51. Caporali R, Montecucco C, Epis O, Bobbio-Pallavicini F, Maio T, Cimmino MA. Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study. Ann Rheum Dis 2001;60:1021-4.","journal-title":"Ann Rheum Dis"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","unstructured":"52. Dasgupta B, Cimmino MA, Maradit-Kremers H, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2012;71:484-92.","journal-title":"Ann Rheum Dis"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/rheumatology\/41.1.46","article-title":"Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using color Doppler ultrasonography of the temporal arteries","volume":"20","author":"Schmidt","year":"2002","unstructured":"53. Schmidt WA, Gromnica-Ihle EJ. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using color Doppler ultrasonography of the temporal arteries. Rheumatology (Oxford) 2002;20:309-18.","journal-title":"Rheumatology (Oxford)"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/s0025-7125(05)70511-3","article-title":"Giant cell arteritis in polymyalgia rheumatica","volume":"102","author":"Hunder","year":"1997","unstructured":"54. Hunder GG. Giant cell arteritis in polymyalgia rheumatica. Am J Med 1997;102:514-16.","journal-title":"Am J Med"},{"key":"ref54","unstructured":"55. Gabriel SE, O'Fallon WM, Achka AA, Lie JT, Hunder GG. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol 1995;22: 93-6."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0002-9343(97)00117-4","article-title":"Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica","volume":"102","author":"Rodriguez-Valverde","year":"1997","unstructured":"56. Rodriguez-Valverde V, Sarabia JM, Gonz\u00e1lez-Gay MA, Figueroa M, Armona, J, Blanco R. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med 1997;102:331-6.","journal-title":"Am J Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0140-6736(12)60680-1","article-title":"Polymyalgia rheumatica","volume":"381","author":"TA","year":"2013","unstructured":"57. Kermani TA, Warrington KJ. Polymyalgia rheumatica. Lancet 2013;381:63-72.","journal-title":"Lancet"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","unstructured":"58. Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 2010;49:1594-7.","journal-title":"Rheumatology (Oxford)"},{"key":"ref58","unstructured":"59. Cimmino MA, Salvarani C, Macchioni P, et al. Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids. Clin Exp Rheumatol 2008;26:395-400."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","unstructured":"60. Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004;50:1332-7.","journal-title":"Arthritis Rheum"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.autrev.2014.02.006","article-title":"Effect of antiplatelet\/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: a cumulative meta-analysis","volume":"13","author":"Martinez-Taboada","year":"2014","unstructured":"61. Martinez-Taboada VM, Lopez-Hoyos M, Narvaez J, Munoz-Cacho P. Effect of antiplatelet\/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: a cumulative meta-analysis. Autoimmun Rev 2014;13:788-94.","journal-title":"Autoimmun Rev"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1136\/annrheumdis-2013-203322","article-title":"Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation)","volume":"73","author":"Garcia-Martinez","year":"2014","unstructured":"62. Garcia-Martinez A, Arguis P, Prieto-Gonzalez S, et al. Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation). Ann Rheum Dis 2014;73:1826-32.","journal-title":"Ann Rheum Dis"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/annrheumdis-2012-202145","article-title":"Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis","volume":"73","author":"Mackie","year":"2014","unstructured":"63. Mackie SL, Hensor EM, Morgan AW, Pease CT. Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis. Ann Rheum Dis 2014;73:143-8.","journal-title":"Ann Rheum Dis"},{"key":"ref63","unstructured":"64. Nesher G, Nesher R, Mates M, Sonnenblick M, Breuer GS. Giant cell arteritis: intensity of the initial systemic inflammatory response and the course of the disease. Clin Exp Rheumatol 2008;26(suppl 49): S30-4."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","unstructured":"65. Mahr AD, Jover JA, Spiera RF, et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 2007;56:2789-97.","journal-title":"Arthritis Rheum"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/rheumatology\/kes127","article-title":"Role of oral cyclophosphamide in the treatment of giant cell arteritis","volume":"51","author":"Quartuccio","year":"2012","unstructured":"66. Quartuccio L, Maset M, De Maglio G, et al. Role of oral cyclophosphamide in the treatment of giant cell arteritis. Rheumatology (Oxford) 2012;51:1677-86.","journal-title":"Rheumatology (Oxford)"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","article-title":"Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomized, double-blind, placebo-controlled trial","volume":"387","author":"Villiger","year":"2016","unstructured":"67. Villiger PM, Adler S, Kuchen S, et al. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomized, double-blind, placebo-controlled trial. Lancet 2016;387:1921-7.","journal-title":"Lancet"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/art.39596","article-title":"Incidence of severe infections and infection-related mortality during the course of giant cell arteritis: a multicenter, prospective, double-cohort study","volume":"68","author":"Schmidt","year":"2016","unstructured":"68. Schmidt J, Smail A, Roche B, et al. Incidence of severe infections and infection-related mortality during the course of giant cell arteritis: a multicenter, prospective, double-cohort study. Arthritis Rheumatol 2016;68: 1477-82.","journal-title":"Arthritis Rheumatol"},{"key":"ref68","unstructured":"69. Nesher G, Sonnenblick M, Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol 1994;21:1283-6."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","article-title":"Mortality in patients with giant cell arteritis","volume":"54","author":"Baslund","year":"2015","unstructured":"70. Baslund B, Helleberg M, Faurschou M, Obel N. Mortality in patients with giant cell arteritis. Rheumatology (Oxford) 2015;54:139-43.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rambam Maimonides Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.rmmj.org.il\/userimages\/597\/1\/PublishFiles\/626Article.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:04:43Z","timestamp":1784808283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rmmj.org.il\/issues\/31\/Articles\/626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,10,31]]}},"URL":"https:\/\/doi.org\/10.5041\/rmmj.10262","relation":{},"ISSN":["2076-9172"],"issn-type":[{"value":"2076-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]}}}